BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27105508)

  • 1. Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo.
    Yu XW; Lin S; Du HZ; Zhao RP; Feng SY; Yu BY; Zhang LY; Li RM; Qian CM; Luo XJ; Yuan ST; Sun L
    Oncotarget; 2016 May; 7(22):32990-3003. PubMed ID: 27105508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis.
    Yu XW; Wei D; Gao YS; Du HZ; Yu BY; Li RM; Qian CM; Luo XJ; Yuan ST; Wang JS; Sun L
    J Cell Mol Med; 2019 Oct; 23(10):6622-6634. PubMed ID: 31397978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo.
    Du H; Liu Y; Chen X; Yu X; Hou X; Li H; Zhan M; Lin S; Lu L; Yuan S; Sun L
    Eur J Pharmacol; 2018 Jan; 818():124-131. PubMed ID: 29037767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
    Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
    Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells.
    Li H; Sun L; Li H; Lv X; Semukunzi H; Li R; Yu J; Yuan S; Lin S
    Cell Death Dis; 2017 May; 8(5):e2810. PubMed ID: 28542137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
    Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G
    Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model.
    Yamashita-Kashima Y; Shu S; Harada N; Fujimoto-Ouchi K
    Oncol Rep; 2013 Sep; 30(3):1087-93. PubMed ID: 23783223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining α-Hederin with cisplatin increases the apoptosis of gastric cancer in vivo and in vitro via mitochondrial related apoptosis pathway.
    Deng H; Ma J; Liu Y; He P; Dong W
    Biomed Pharmacother; 2019 Dec; 120():109477. PubMed ID: 31562979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer.
    Liu H; Lu J; Hua Y; Zhang P; Liang Z; Ruan L; Lian C; Shi H; Chen K; Tu Z
    Cell Death Dis; 2015 Jan; 6(1):e1595. PubMed ID: 25590805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
    Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
    Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Straughn JM; Oliver PG; Zhou T; Wang W; Alvarez RD; Grizzle WE; Buchsbaum DJ
    Gynecol Oncol; 2006 Apr; 101(1):46-54. PubMed ID: 16271751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
    Wildner O; Blaese RM; Morris JC
    Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
    Bruzzese F; Di Gennaro E; Avallone A; Pepe S; Arra C; Caraglia M; Tagliaferri P; Budillon A
    Clin Cancer Res; 2006 Jan; 12(2):617-25. PubMed ID: 16428508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DT-13, a saponin monomer 13 of the Dwarf lilyturf tuber, synergized with vinorelbine to induce mitotic arrest via activation of ERK signaling pathway in NCI-H1299 cells.
    Li H; Sun L; Li H; Lv X; Semukunzi H; Li R; Yu J; Yuan S; Lin S
    Biomed Pharmacother; 2017 May; 89():1277-1285. PubMed ID: 28320095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.
    LaBonte MJ; Manegold PC; Wilson PM; Fazzone W; Louie SG; Lenz HJ; Ladner RD
    Int J Cancer; 2009 Dec; 125(12):2957-69. PubMed ID: 19536776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells.
    Kim MK; James J; Annunziata CM
    BMC Cancer; 2015 Mar; 15():196. PubMed ID: 25884494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer.
    Yang Z; Zhang SL; Hu X; Tam KY
    Eur J Pharmacol; 2018 Nov; 838():41-52. PubMed ID: 30213498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment.
    Du H; Huang Y; Hou X; Yu X; Lin S; Wei X; Li R; Khan GJ; Yuan S; Sun L
    Oncol Rep; 2016 Aug; 36(2):721-8. PubMed ID: 27350172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR2 gene amplification in gastric cancer predicts sensitivity to the selective FGFR inhibitor AZD4547.
    Xie L; Su X; Zhang L; Yin X; Tang L; Zhang X; Xu Y; Gao Z; Liu K; Zhou M; Gao B; Shen D; Zhang L; Ji J; Gavine PR; Zhang J; Kilgour E; Zhang X; Ji Q
    Clin Cancer Res; 2013 May; 19(9):2572-83. PubMed ID: 23493349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans retinoic acid synergizes with topotecan to suppress AML cells via promoting RARα-mediated DNA damage.
    Xu Z; Shao J; Li L; Peng X; Chen M; Li G; Yan H; Yang B; Luo P; He Q
    BMC Cancer; 2016 Jan; 16():2. PubMed ID: 26728137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.